Project Grant K23AG088502
Award Date
8/15/24
Completion Date
5/31/29
Dollars Obligated
$188K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
New York, NY 10021, USA
Similar Awards
This Project Grant award from the National Institute on Aging (NIA), under the Aging Research (CFDA 93.866) Federal Grant Program, supports research into the mechanisms of inflammatory osteoblastogenesis and bone formation. The $688,634 award to The Hospital For Special Surgery Fund, Inc. (doing business as HSS Foundation) will fund a 5-year investigation into how the constitutive type-I interferon response in osteoblasts suppresses bone formation, and how this is influenced by aging and...
This Project Grant award of $300,000.00 from the U.S. Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program supports research by the New York Society For Relief Of Ruptured & Crippled Maintaining The Hospital For Special Surgery into "Novel Mechanisms That Prevent SLE" over the period from September 1, 2025 to August 31, 2027. The award aims to advance disease prevention, diagnosis, treatment, and management...
The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a $1,800,418 Project Grant to Neuromuscular Dynamics LLC to clinically validate and enable a go-to-market strategy for their Leg Dexterity System. This patented, portable device is designed for home-based, short-latency sensorimotor neuromuscular training to help manage knee osteoarthritis (OA) through non-surgical means. The project will conduct a longitudinal, blinded trial comparing...
This Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports a research study at Duke University to investigate the effects of exercise training on T cell function, metabolism, and aging in patients with rheumatoid arthritis (RA). The award, totaling $160,834 and running from August 15, 2024 to April 30, 2029, will enable the principal investigator to: 1) Determine if a remotely supervised caloric restriction and exercise training (CRET) program leads...
This $299,820 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will fund a feasibility study on a telehealth-delivered mindful exercise intervention for people with knee osteoarthritis. The study aims to determine the feasibility of the mindful exercise program compared to telehealth-delivered exercise alone, as well as the feasibility of...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $317,304 to Duke University to develop and test a digital intervention aimed at improving adherence to hydroxychloroquine among adolescents with pediatric systemic lupus erythematosus (PSLE). The key goals of the project are to: 1) define an objective hydroxychloroquine concentration...
This Project Grant award from the National Institute on Aging's Aging Research Federal Grant Program (CFDA 93.866) provides $616,809 to the University of South Carolina to optimize a remote-based physical activity intervention for adults with total knee replacement. The goal is to identify the optimal combination of intervention components, including 0-4 supplemental non-automated components, to increase physical activity levels in this population. The primary aim is to determine which...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), will support research to investigate the role of Langerhans cells in regulating lymphatic function and immune tolerance in systemic lupus erythematosus (SLE). The $788,508 award to The Hospital for Special Surgery Fund, Inc. will fund a 5-year study to delineate the mechanisms by which Langerhans...
This Project Grant award of $405,350.00 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The research aims to characterize lipid droplets in macrophage subsets and determine if manipulating lipid droplet content can shift macrophage function, with the goal of uncovering new therapeutic targets for systemic lupus erythematosus (SLE). The award recipient is The...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded a $216,113 Project Grant (CFDA 93.846 - Arthritis, Musculoskeletal and Skin Diseases Research) to New York University (NYU) School of Medicine to investigate the mechanisms underlying hematological abnormalities in systemic autoimmune diseases like systemic lupus erythematosus (SLE). The research aims to characterize impairments in hematopoietic stem cell (HSC) activity and the epigenetic changes in...